Used primarily as a key intermediate in pharmaceutical synthesis, especially in Suzuki-Miyaura cross-coupling reactions to construct complex organic molecules. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in the development of active pharmaceutical ingredients (APIs). Commonly applied in the preparation of nitrogen-containing heterocyclic compounds, which are prevalent in drugs targeting central nervous system disorders and oncology. Its cyclopropyl and tetrahydropyridine moieties contribute to enhanced metabolic stability and binding affinity in drug candidates. Suitable for use in late-stage functionalization due to its compatibility with various functional groups under mild reaction conditions.